New tablet tool aims to ease emotional burden for ICU Decision-Makers

NCT ID NCT07630844

Not yet recruiting Symptom relief Sponsor: Case Western Reserve University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests REFRAME, a short tablet-based program designed to help family members manage overwhelming emotions when making medical decisions for critically ill loved ones in the ICU. About 387 participants will be randomly assigned to either REFRAME or an informational support program. The goal is to see if REFRAME reduces depressive symptoms and improves emotional regulation, potentially leading to a widely available tool for families in crisis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: REFRAME (a tablet-based emotion regulation program)
What this could lead to: If it works, this could provide a simple, widely accessible tool to reduce emotional suffering and improve medical decision-making for families in crisis.
What could go wrong: This is an early-stage behavioral trial with no drug involved, so the effect may be small or not generalizable. Results depend on participants' engagement and may not apply to all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness Emotional Regulation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CRITICAL ILLNESS

Contacts and locations

Locations

University Hospitals Cleveland Medical Center

Cleveland, Ohio, 44106, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.